Mobile

Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

Mise à jour : Il y a 4 ans
Référence : NCT01563471

Femme et Homme

  • | Pays :
  • France
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This trial is conducted in Europe. The aim of this trial is to investigate the pharmacokinetics of three different single doses activated recombinant human factor VII in Caucasian and Japanese healthy subjects.

Critère d'inclusion

  • Congenital Bleeding Disorder ,Haemophilia A With Inhibitors ,Haemophilia B With Inhibitors ,Healthy

Liens